Physiological separation of Alzheimer's disease and Alzheimer's disease with significant levels of cerebrovascular symptomology and healthy controls

被引:11
|
作者
Lithgow, Brian J. [1 ,2 ]
Dastgheib, Zeinab [1 ]
Anssari, Neda [3 ]
Mansouri, Behzad [1 ,3 ]
Blakley, Brian [4 ]
Ashiri, Mehrangiz [1 ]
Moussavi, Zahra [1 ]
机构
[1] Univ Manitoba, Riverview Hlth Ctr, Diagnost & Neurosignal Proc Res Lab, Biomed Engn Program, Winnipeg, MB, Canada
[2] Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia
[3] Brain Vis & Concuss Clin iScope, Vis Matter Res Ins, Winnipeg, MB, Canada
[4] Hlth Sci Ctr, Dept Otolaryngol, Winnipeg, MB, Canada
关键词
Alzheimer's disease; Cerebrovascular symptomatology; Mixed dementia; Vascular dementia; Electrovestibulography; Biomarkers; MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; CLINICAL-DIAGNOSIS; NATIONAL INSTITUTE; DEMENTIA; STIMULATION; PERFORMANCE; PROGRESSION; RECEPTORS;
D O I
10.1007/s11517-021-02409-8
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Most dementia patients with a mixed dementia (MxD) diagnosis have a mix of Alzheimer's disease (AD) and vascular dementia. Electrovestibulography (EVestG) records vestibuloacoustic afferent activity. We hypothesize EVestG recordings of AD and MxD patients are different. All patients were assessed with the Montreal cognitive assessment (MoCA) and Hachinski ischemic scale (HIS) (>4 HIS score <7 is representative of MxD cerebrovascular symptomology). EVestG recordings were made from 26 AD, 21 MxD and 44 healthy (control) participants. Features were derived from the EVestG recordings of the average field potential and field potential interval histogram to classify the AD, MxD and control groups. Multivariate analysis was used to test the features' significance. Using a leave-one-out cross-validated linear discriminant analysis with 3 EVestG features yielded accuracies > 80% for separating pairs of AD/MxD/control. Using the MoCA assessment and 2 EVestG features, a best accuracy of 81 to 91% depending on the classifier was obtained for the 3-way identification of AD, MxD and controls. EVestG measures provide a physiological basis for identifying AD from MxD. EVestG measures are hypothesized to be partly related to channelopathies and changes in the descending input to the vestibular periphery. Four of the five AD or MxD versus control features used had significant correlations with the MoCA. This supports assertions that the pathologic changes associated with AD impact the vestibular system and further are suggestive that the postulated physiological changes behind these features have an association with cognitive decline severity.
引用
收藏
页码:1597 / 1610
页数:14
相关论文
共 50 条
  • [31] An anemia of Alzheimer's disease
    Faux, N. G.
    Rembach, A.
    Wiley, J.
    Ellis, K. A.
    Ames, D.
    Fowler, C. J.
    Martins, R. N.
    Pertile, K. K.
    Rumble, R. L.
    Trounson, B.
    Masters, C. L.
    Bush, A. I.
    MOLECULAR PSYCHIATRY, 2014, 19 (11) : 1227 - 1234
  • [32] Differences in Aβ brain networks in Alzheimer's disease and healthy controls
    Duan, Huoqiang
    Jiang, Jiehui
    Xu, Jun
    Zhou, Hucheng
    Huang, Zhemin
    Yu, Zhihua
    Yan, Zhuangzhi
    BRAIN RESEARCH, 2017, 1655 : 77 - 89
  • [33] Oxidative Stress in the Pathogenesis of Alzheimer's Disease and Cerebrovascular Disease with Therapeutic Implications
    Jurcau, Anamaria
    Simion, Aurel
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2020, 19 (02) : 94 - 108
  • [34] Stress and Alzheimer's disease
    Escher, Claus M.
    Sannemann, Lena
    Jessen, Frank
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (09) : 1155 - 1161
  • [35] Influence of cerebrovascular disease on brain networks in prodromal and clinical Alzheimer's disease
    Chong, Joanna Su Xian
    Liu, Siwei
    Loke, Yng Miin
    Hilal, Saima
    Ikram, Mohammad Kamran
    Xu, Xin
    Tan, Boon Yeow
    Venketasubramanian, Narayanaswamy
    Chen, Christopher Li-Hsian
    Zhou, Juan
    BRAIN, 2017, 140 : 3012 - 3022
  • [36] Biomarkers for Alzheimer's disease
    Ward, Malcolm
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2007, 7 (05) : 635 - 646
  • [37] 2013 Alzheimer's disease facts and figures Alzheimer's Association
    Thies, William
    Bleiler, Laura
    ALZHEIMERS & DEMENTIA, 2013, 9 (02) : 208 - 245
  • [38] Decreased salivary lactoferrin levels are specific to Alzheimer's disease
    Gonzalez-Sanchez, Marta
    Bartolome, Fernando
    Antequera, Desiree
    Puertas-Martin, Veronica
    Gonzalez, Pilar
    Gomez-Grande, Adolfo
    Llamas-Velasco, Sara
    Herrero-San Martin, Alejandro
    Perez-Martinez, David
    Villarejo-Galende, Alberto
    Atienza, Mercedes
    Palomar-Bonet, Miriam
    Luis Cantero, Jose
    Perry, George
    Orive, Gorka
    Ibanez, Borja
    Bueno, Hector
    Fuster, Valentin
    Carro, Eva
    EBIOMEDICINE, 2020, 57 : 102834
  • [39] Plasma neurofilament light chain levels in Alzheimer's disease
    Zhou, Wenjun
    Zhang, Jie
    Ye, Fanlong
    Xu, Guangzheng
    Su, Hang
    Su, Yindan
    Zhang, Xiangyang
    NEUROSCIENCE LETTERS, 2017, 650 : 60 - 64
  • [40] Alzheimer's disease
    Lane, C. A.
    Hardy, J.
    Schott, J. M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (01) : 59 - 70